Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Retained Earnings (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Retained Earnings readings, the most recent being -$334.7 million for Q4 2021.

  • On a quarterly basis, Retained Earnings fell 17.52% to -$334.7 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$334.7 million, a 17.52% decrease, with the full-year FY2021 number at -$334.7 million, down 17.52% from a year prior.
  • Retained Earnings hit -$334.7 million in Q4 2021 for Minerva Neurosciences, down from -$313.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$277.5 million in Q3 2020 to a low of -$344.5 million in Q1 2021.
  • Median Retained Earnings over the past 3 years was -$304.2 million (2021), compared with a mean of -$305.4 million.
  • Biggest five-year swings in Retained Earnings: increased 0.68% in 2020 and later dropped 17.52% in 2021.
  • Minerva Neurosciences' Retained Earnings stood at -$286.7 million in 2019, then grew by 0.68% to -$284.8 million in 2020, then decreased by 17.52% to -$334.7 million in 2021.
  • The last three reported values for Retained Earnings were -$334.7 million (Q4 2021), -$313.4 million (Q3 2021), and -$304.2 million (Q2 2021) per Business Quant data.